CenExel highlights industry-leading capabilities amid growing FDA momentum advancing psychedelic clinical research
The FDA recently announced it is shifting regulatory attention and investment for emerging psychedelic-based therapeutics treating mental health conditions. CenExel Clinical Research is answering this push with expansion to support psychedelic...

